| Addiction Treatment Gap Is Driving a Black Market for Suboxone |
| NPR (10/05) – […] Buprenorphine is one of just three federally approved medications to treat opioid addiction. It's an opioid itself, so some people misuse it — they snort or inject the medication to get high. And patients who have prescriptions for buprenorphine sometimes sell or give it away, which is known as diversion. Read more |
|
|
|
| Don't Treat E-Cigarettes Like Cigarettes, Say Experts |
SCIENCE DAILY (10/01) – "Cigarette" might appear in the term "e-cigarette" but that is as far as their similarities extend, reports a new Northwestern Medicine report published Friday, Sept. 28, in the journal Nicotine & Tobacco Research. Assuming e-cigarettes are equal to cigarettes could lead to misguided research and policy initiatives, the paper says. Read more
Further Reading:
|
|
|
|
| Fentanyl Test Strips Lead to More Caution Among Illicit Drug Users |
| THE WASHINGTON POST (10/03) – Illicit drug users who are certain that fentanyl is mixed into the heroin they consume are much more likely to take precautions that reduce their chances of overdosing, researchers reported Wednesday in a small study. Read more |
|
|
|
 |
|
|
| At-Risk Teens and Young Adults Overlooked During Opioid Crisis |
| MEDICAL XPRESS (10/04) – Teens and young adults who have injected drugs are at risk for contracting hepatitis C, but most aren't tested and therefore don't receive life-saving treatment, according to a national study being presented at IDWeek 2018. The study of more than 250,000 at-risk youth found only one-third of those with diagnosed opioid use disorder (OUD) were tested for hepatitis C. Read more |
|
|
|
| FDA Staff Raises Safety Concerns Over Trevena Opioid Drug |
| REUTERS (10/09) – Staff reviewers of the U.S. Food and Drug Administration on Tuesday raised safety concerns over Trevena Inc’s opioid injection to treat acute pain, saying the treatment has an abuse and overdose potential. The treatment, oliceridine, aims to manage moderate-to-severe acute pain in adult patients for whom an intravenous opioid is warranted. Read more |
|
|
|
| New Kit Check Technology Seeks to Pinpoint Drug Theft and Misuse |
| MEDCITY NEWS (10/10) – Kit Check, a Washington, D.C.-based company focused on automated medication management, has released a new feature: Individual Risk Identification Score (or IRIS), which allows hospital staff to pinpoint employees who pose a high risk for drug diversion. More specifically, the technology relies on machine learning to find abnormal behavior and curb the misuse of controlled substances. Read more |
|
|
|
 |
|
|
| NIH director: US Needs More Treatments for Opioid Addiction, Chronic Pain |
| USA TODAY (10/03) – The head of the National Institutes of Health said Wednesday that science can help the nation find newer and smarter ways out of an epidemic that resulted in more than 49,000 opioid overdose deaths last year. NIH Director Francis Collins told the USA TODAY Editorial Board that his agency will fund new, longer-lasting treatments for more than 2 million Americans addicted to opioids, and develop nonaddictive therapies for the estimated 25 million who suffer chronic pain. Read more |
|
|
|
| Teen Cannabis Use is Not Without Risk to Cognitive Development |
| SCIENCE DAILY (10/03) – Although studies have shown that alcohol and cannabis misuse are related to impaired cognition in youth, previous studies were not designed to understand this relationship and differentiate whether cannabis use was causal or consequential to cognitive impairment. Read more |
|
|
|
| Study Specifies the Neuropsychological Deficits of Alcoholic Abusers |
| MEDICAL XPRESS (09/27) – A University of Valencia psychology and neuroscience team has defined the specific neuropsychological profile of men with several patterns of alcohol consumption and a history of violence against women in couple relationships. The study, published in Alcohol, seeks to facilitate adherence to treatment, as well as the detection of the chances of a relapse of abusers who are brought before a court. Read more |
|
 | Why use SASSI screening questionnaires: |
|
 | |
- Identifies SUD – even when someone is reluctant to self-disclose.
- Accurately identifies individuals likely to be abusing prescription medications.
- Screens for multiple levels of severity.
- Distinguishes likely SUD from other psychological disorders.
- Useful in developing treatment plans and goals.
- Available for adults, adolescents, and special populations.
TRAINING AVAILABLE - NAADAC CEUs |
|
|
|
|
| Congress Targets Misuse of Hospice Drugs |
| KAISER HEALTH NEWS (10/04) – Hospice workers would be allowed to destroy patients’ unneeded opioids, reducing the risk that families misuse them, according to one little-noticed provision in the bipartisan opioids bill headed to President Donald Trump’s desk for his likely signature. The bill would empower hospice staff to destroy opioid medications that are expired, no longer needed by the patient because of a change in treatment or left over after the patient dies. Read more |
|
|
|
| No, the DEA Did Not Reschedule the CBD Compound |
| FORBES (09/28) – There is a certain level of confusion reverberating throughout the cannabis community right now over the DEA’s recent decision to make Epidiolex, the cannabis-based epilepsy drug created by GW Pharmaceuticals, a Schedule V controlled substance. Some folks are convinced that since this FDA-approved medication is pure cannabidiol (CBD) that all CBD products fall into the same category. Read more |
|
|
|
| Employee Mental Health, Substance Abuse Issues Increase |
| BIZWOMEN (10/11) – Mental health and substance abuse problems among employees have grown. Sixty percent of U.S. and Canadian organizations say they're seeing more of those issues than two years ago, according to the International Foundation of Employee Benefit Plans. In addition, 40 percent of organizations report their employees are very or extremely stressed, and almost 40 percent say stress levels are higher now compared with two years ago. Read more |
|
|
|
 |
|
|
| FDA Seizes Documents from E-Cigarette Maker Amid Crackdown on Flavored Vapes |
| NPR (10/03) – Chocolate cupcake, creme, mango, tutti frutti, "blue" — sugary-sounding flavors familiar to teenage e-cigarette users are facing more crackdowns from the Food and Drug Administration. The FDA seized more than 1,000 pages of documents during a "surprise inspection" at Juul Labs, an electronic cigarette company based in San Francisco. Read more |
|
|
|
| How to Help Pain Patients Cut Back on Opioids |
| SCIENTIFIC AMERICAN (10/2018) – [...] Alas, few of the 10 million or so Americans taking opioids long term for chronic pain have access to such a stellar program. Around the country, state and federal authorities and insurance companies are cracking down on opioid prescriptions in the wake of a 345 percent spike in opioid-related deaths between 2001 and 2016. Read more |
|
|
|
| Club Drug GHB Associated with Brain and Cognitive Changes |
| SCIENCE DAILY (10/08) – Scientists have discovered that regular use of the party drug GHB, and especially unconsciousness following GHB use, is associated with brain changes including negative effects on long-term memory, working memory, IQ, and higher levels of stress and anxiety. This work is presented at the ECNP conference in Barcelona, following partial peer-review publication. Read more |
|
No comments:
Post a Comment